Johan Luthman

Chief Tech/Sci/R&D Officer at H. LUNDBECK A/S

Net worth: 908 412 $ as of 2026-01-30

67 year

Health Technology

Consumer Services

Profile

Johan Luthman is EVP & Head-Research & Development at H. Lundbeck A. In the past Dr. Luthman was Chief Executive Officer at GeNeuro SA (Switzerland) and Head-Neuroscience Research at Merck Serono GmbH. Dr. Luthman received an undergraduate degree from Karolinska Institutet.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
H. LUNDBECK A/S CLASS B 0.01%	2025-12-30	112,592 ( 0.01% )	755 492 $	2026-01-30
H. LUNDBECK A/S CLASS A 0.01%	2025-12-30	26,049 ( 0.01% )	152 919 $	2026-01-30

Johan Luthman active positions

Companies	Position	Start
H. LUNDBECK A/S	Chief Tech/Sci/R&D Officer	2019-02-28
BRAIN+ A/S	Director/Board Member	2024-04-30

All active positions of Johan Luthman

Former positions of Johan Luthman

Companies	Position	End
Merck Serono GmbH Merck Serono GmbH Manufactures and distributes pharmaceuticals products	Corporate Officer/Principal	2013-11-30
GENEURO SA	Chief Executive Officer	2009-07-31
Eisai GmbH Eisai GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products	Corporate Officer/Principal	-

See the detail of Johan Luthman's experience

Training of Johan Luthman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Johan Luthman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
H. Lundbeck A/S H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases	Health Technology
Karolinska Institutet Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Eisai GmbH Eisai GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products	Health Technology
Brain+ A/S Brain+ A/S Develops medical software to detect and treat the cognitive symptoms of dementia
GeNeuro SA (Switzerland) GeNeuro SA (Switzerland) Engages in the research and development of pharmaceutical products to treat neurological diseases
Merck Serono GmbH Merck Serono GmbH Manufactures and distributes pharmaceuticals products